Colorectal, breast and lung cancer Cancer Colorectal cancer, breast cancer, lung cancer
Conditions
Interventions
This study will evaluate the effectiveness of using a mobile phone in the home, monitoring and symptom management of patients receiving chemotherapy for colorectal cancer, lung and breast cancer. Part
Sponsors
University of Stirling (UK)
Eligibility
Inclusion criteria
Inclusion criteria: 1. A diagnosis of breast, lung or colorectal cancer 2. Commencing a new course of chemotherapy treatment (defined as those patients commencing a new chemotherapy regime irrespective of stage of disease or line of treatment) 3. Receiving out-patient chemotherapy 4. Aged 18 years or over 5. Written informed consent given 6. Able to read and write English 7. Deemed by members of the clinical team as being physically and psychologically fit to participate in the study
Exclusion criteria
Exclusion criteria: 1. Patients who are unable to meet the above criteria 2. Patients who do not agree to give access to their case notes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in chemotherapy toxicity as a result of use of the mobile phone system and supporting information technology (IT) infrastructure | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptom outcomes that will be used for future statistical power calculations | — |
Countries
United Kingdom
Outcome results
None listed